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A double-blind placebo controlled randomised trial on using progesterone from first trimester to reduce the incidence of preterm birth in ICSI twins Objectives: To study the effectiveness of administering natural progesterone from the first trimester till 37 weeks or delivery, in reducing the incidence of preterm birth in twin pregnancies conceived through IVF/ICSI. Methods: This is a double blind placebo controlled single centre randomised trial. Patients pregnant with dichorionic twins following an IVF/ICSI cycle were randomised after the first trimester scan at 11-14 weeks, to either 400mg X 2 daily rectal progesterone suppositories versus Placebo. Patients were followed up by routine antenatal care monthly. The primary outcome was preterm birth rate before 37 weeks of gestation. The secondary outcomes were; preterm birth rates <34, 32 & 28 weeks and adverse neonatal outcomes including NICU admission. Results: A total of 197 patients were included in the final analysis,101 received progesterone, 96 received placebo.The mean gestational age at delivery was 34.7 3.8 weeks for the progesterone group & 34.4 4.5 for the Placebo group (P=0.638). No statistical difference was found between preterm birth rates in both groups progesterone & placebo respectively at all gestational ages; < 37 (71.8 % vs 66%, P=0.368), <34 (20 % vs 21%, P=0.602), <32(8.7% vs 14%, p=0.445), <28 weeks (4.9% vs 3%, P=0.506). No statistical difference was found in number of NICU admissions nor adverse neonatal outcomes between both groups. The take home baby rate of both twins was similar in both groups; 80% (P=0.41). Conclusions: Daily rectal natural progesterone from the first trimester onwards in twin IVF/ICSI pregnancies does not reduce the incidence of preterm birth nor adverse neonatal outcomes.
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The predictive accuracy of the STORK chorionicity-specific twin growth charts for stillbirth: a validation study Objectives: Despite the fact that the growth pattern has been shown to differ in twins compared to singletons, it is controversial whether twin-specific growth charts should be routinely used. The main aim of this study was to compare the performance of chorionicity-specific twin charts with singleton charts, both customised and non-customised, in the antenatal prediction of SGA stillborn and liveborn fetuses. Methods: This was a multicentre cohort study analysing data from the STORK multiple pregnancy cohort (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) ) and a second cohort of twin pregnancies at St. George's University Hospital (SGH) (2011) (2012) (2013) (2014) (2015) (2016) . The EFW available from the last scan (>24 weeks) before delivery or demise was used to classify the fetuses as SGA or appropriate for gestational age. The proportions of SGA stillbirths and SGA livebirths predicted were calculated using the three different charts.
Results:
The STORK cohort consisted of 1850 DC and 300 MC pregnancies. The SGH cohort consisted of 579 DC and 180 MC pregnancies. In those liveborn in the STORK cohort, the non-customised singleton chart identified a significantly greater proportion as SGA compared to the twin chart, regardless of chorionicity (p<0.001). However, there was no significant difference between the twin and the non-customised singleton charts in the proportion of stillbirth cases that were SGA (p=0.479).
In the SGH cohort, the non-customised singleton chart identified 8.5% of liveborn fetuses as SGA compared to 12.8% using the customised singleton chart and 7.1% using the twin chart (p=0.005 and p<0.001, respectively). However, there was no significant difference among the three charts in the proportion of stillbirths identified as SGA, regardless of chorionicity (p=0.999). Conclusions: Compared to the STORK twin charts, the customised or non-customised singleton charts identified more liveborn fetuses as SGA. However, the 3 charts identified a similar proportion of stillbirth SGA cases. Our results suggest that twin charts could safely reduce unnecessary medical intervention in twin pregnancies. 
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